All In Biotech

Drug Trial Radar · NCT07440381

triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE

triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE (PERSUADE) Trial

Last checked: Nov 20, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingPhase 3. Randomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

600

Planned (sponsor's estimate)

Start

Sep 2026

Primary completion

Aug 2027

Study completion Aug 2027

Sponsor

Lead sponsor
Heart Care FoundationAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
First posted
Feb 27, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Early and intensive LDL-cholesterol (LDL-c) reduction is associated with improved short-term and long-term outcomes. Bempedoic acid is an oral ATP citrate lyase inhibitor that lowers LDL-c upstream of HMG-CoA reductase. When added to maximally tolerated statins, it has demonstrated significant LDL-c reduction and cardiovascular benefit, particularly in statin-intolerant or high-risk patients. However, evidence on early initiation of bempedoic acid during the index ACS hospitalization is currently lacking. The investigators therefore would like to see whether early (pre-discharge) initiation of an oral triple lipid-lowering therapy including bempedoic acid, high-intensity statin (HIS), and ezetimibe is superior to usual care in reducing LDL-c levels at 8 weeks after randomization in patients hospitalized for ACS.

Conditions

  • Acute Coronary Syndromes
  • Secondary Prevention
  • Lipids

Interventions

  • Triple oral lipid lowering treatmentDrug

    Triple oral lipid lowering treatment including high intensity statin, ezetimibe and bembedoic acid

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean percent change in LDL-c levelsTime frame: 8 weeks

Locations

35 sites in 1 country. Site status is shown where the registry gives one.

  • Ospedale Miulli - U.O.C. CARDIOLOGIA - UTIC

    Acquaviva delle Fonti, Italy

  • Ospedale Della Murgia - Fabio Perinei - S.C. Cardiologia-Utic

    Altamura, Italy

  • Ospedale San Donato - U.O.C Cardiologia

    Arezzo, Italy

  • Aorn San Giuseppe Moscati - U.O. Cardiologia/Utic 'D. Rotiroti'

    Avellino, Italy

  • Ospedale San Paolo - Cardiologia-Utic

    Bari, Italy

  • Ospedale Santo Spirito - SC Cardiologia

    Casale Monferrato, Italy

  • Azienda Ospedaliera S. Anna E S. Sebastiano - U.O. Cardiologia D'Emergenza Con Utic

    Caserta, Italy

  • Azienda Ospedaliera Cannizzaro - Uoc Cardiologia

    Catania, Italy

  • OSPEDALE PIO XI - UOC di Cardiologia

    Desio, Italy

  • Presidio Ospedaliero "Santa Maria Del Prato" - U.O.C. Di Cardiologia-Utic

    Feltre, Italy

  • Arcispedale Sant'Anna - U.O. Cardiologia

    Ferrara, Italy

  • Aou Careggi - Interventistica Cardiologica Strutturale

    Florence, Italy

  • Policlinico Riuniti - S.C. Di Cardiologia Universitaria-Utic

    Foggia, Italy

  • Ospedale Del Tigullio Polo Lavagna - Sc Cardiologia E Utic

    Lavagna, Italy

  • OSPEDALE CIVILE FORNAROLI - UO Cardiologia

    Magenta, Italy

  • Asst Ospedale Metropolitano Niguarda - Cardiologia 1 - Emodinamica

    Milan, Italy

  • Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico - Uoc Malattie Cardiovascolari

    Milan, Italy

  • Irccs Ospedale Galeazzi - Sant'Ambrogio - Cardiologia Universitaria Ed Imaging Cardiaco

    Milan, Italy

  • Ospedale Policlinico - Uoc Di Cardiologia

    Modena, Italy

  • Aou Policlinico P. Giaccone - U.O.C. Cardiologia

    Palermo, Italy

  • Arnas P.O. Civico E Benfratelli - Uoc Utic

    Palermo, Italy

  • FONDAZIONE IRCCS POLICLINICO SAN MATTEO - UOC Cardiologia

    Pavia, Italy

  • Ospedale Santo Spirito - Cardiologia Con Utic

    Pescara, Italy

  • Ospedale San Jacopo - Soc Cardiologia

    Pistoia, Italy

  • Aor San Carlo - Ospedale San Carlo - Ssd Terapia Intensiva Cardiologica

    Potenza, Italy

  • Ospedale Giovanni Paolo Ii - U.O.C. Cardiologia-Utic

    Ragusa, Italy

  • Po Santa Maria Nuova - Ausl Re Irccs - Soc Cardiologia Ospedaliera

    Reggio Emilia, Italy

  • OSPEDALE DEGLI INFERMI - SC Cardiologia

    Rivoli, Italy

  • Ospedale San Camillo - Uoc Cardiologia

    Roma, Italy

  • P.O. San Filippo Neri - Asl Roma 1 - Cardiologia Clinica E Riabilitativa

    Roma, Italy

  • PRESIDIO OSPEDALIERO - UO Cardiologia

    Sanremo, Italy

  • P.O. Levante - Ospedale San Paolo - S.C. Cardiologia Levante

    Savona, Italy

  • OSPEDALE SANTA CHIARA - Divisione di Cardiologia

    Trento, Italy

  • OSPEDALE CA' FONCELLO - UOC Cardiologia

    Treviso, Italy

  • Nuovo Ospedale Di Vimercate - S.C. Cardiologia E Utic

    Vimercate, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.